Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VHT vs. RXL: which is better?

Bottom line

VHT vs RXL: the short answer

VHT (Vanguard Health Care Index Fund) and RXL (ProShares Ultra Health Care) share a meaningful slice of their top holdings — about 76% by weight.

But VHT is far broader, holding 407 positions to 70 for RXL, so beyond the top names it adds exposure RXL doesn't have.

VHT is cheaper at 0.09% vs 0.95% — a difference of $86 a year per $10,000 invested.

Over five years, VHT returned +7.2% a year vs +7.2% for RXL (reporting dates differ).

Updated Nov 19, 2026

VHT vs RXL side by side

VHTRXL
TypeETFETF
Fund familyVanguardProShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.09%0.95%
Annual cost per $10k$9$95
10-yr cost on $10k (prospectus)$115$1,305
Max front loadNoneNone
12b-1 fee0%—
1-yr return+2.7%+19.7%
5-yr return (annualized)+7.2%+7.2%
10-yr return (annualized)+8.8%+12.6%
Best quarter+16.5%+29.7%
Worst quarter−13.1%−28.9%
Net assets (fund)$19.0B$72.1M
Number of holdings40770
Portfolio turnover4%4%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearVHTRXLDifference
2024+2.7%−2.7%+5.3%
2023+2.5%−3.2%+5.7%
2022−5.5%−15.1%+9.6%
2021+20.5%+47.8%−27.3%
2020+18.2%+19.2%−1.0%
2019+22.0%+38.9%−16.9%
2018+5.6%+5.4%+0.2%
2017+23.3%+46.0%−22.7%
2016−3.3%−8.9%+5.6%

Source: Fund prospectus bar charts

Holdings overlap

20 of VHT's top 25 holdings also appear in RXL's top 25.

Shared top holdings
HoldingVHTRXL
Eli Lilly & Co14.04%12.67%
Johnson & Johnson8.47%7.86%
AbbVie Inc6.09%5.57%
UnitedHealth Group Inc5.45%4.98%
Merck & Co Inc4.66%4.26%
Thermo Fisher Scientific Inc2.93%2.68%
Amgen Inc2.87%2.62%
Gilead Sciences Inc2.64%2.41%
Intuitive Surgical Inc2.38%2.18%
Pfizer Inc2.35%2.15%
Abbott Laboratories2.35%2.15%
Bristol-Myers Squibb Co1.84%1.68%
Danaher Corp1.84%1.66%
CVS Health Corp1.83%1.67%
Vertex Pharmaceuticals Inc1.80%1.64%

Source: SEC Form N-PORT

VHT top 10

  1. Eli Lilly & Co — 14.04%
  2. Johnson & Johnson — 8.47%
  3. AbbVie Inc — 6.09%
  4. UnitedHealth Group Inc — 5.45%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 2.93%
  7. Amgen Inc — 2.87%
  8. Gilead Sciences Inc — 2.64%
  9. Intuitive Surgical Inc — 2.38%
  10. Pfizer Inc — 2.35%

RXL top 10

  1. Eli Lilly & Co. — 12.67%
  2. ProShares GENIUS Money Market ETF — 11.81%
  3. Johnson & Johnson — 7.86%
  4. AbbVie, Inc. — 5.57%
  5. UnitedHealth Group, Inc. — 4.98%
  6. Merck & Co., Inc. — 4.26%
  7. Repurchase Agreement — 2.91%
  8. Thermo Fisher Scientific, Inc. — 2.68%
  9. Amgen, Inc. — 2.62%
  10. Gilead Sciences, Inc. — 2.41%

FAQ

What is the difference between VHT and RXL?
VHT (Vanguard Health Care Index Fund) and RXL (ProShares Ultra Health Care) share a meaningful slice of their top holdings — about 76% by weight. But VHT is far broader, holding 407 positions to 70 for RXL, so beyond the top names it adds exposure RXL doesn't have.
Which is cheaper, VHT or RXL?
VHT has the lower expense ratio (0.09%).
Should I own both VHT and RXL?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.